One evening. One rare cancer field. A global conversation on what comes next.
Sarcoma care is entering a new and exciting chapter, shaped by deeper biology, smarter biomarkers, emerging immune strategies, and novel therapeutic platforms. At ASCO 2026 in Chicago, OncoDaily is bringing this conversation to life through a special live program: OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition.
REGISTRATION
This is not just another meeting session. It is a focused gathering designed for clinicians, researchers, industry leaders, and oncology professionals who want to understand where the sarcoma field is moving and why it matters now.
Co-chaired by Dr. Sandra D’Angelo and Dr. Herbert Loong, the program will bring together internationally recognized experts for a dynamic discussion on the science and strategy shaping modern sarcoma care. From targeted therapies and biomarker testing to immuno-oncology combinations, T-cell receptor therapy, antibody drug conjugates, and novel therapeutics, the session will explore the questions that are defining the future of treatment for these rare and complex cancers.
The evening will feature expert talks from Dr. Robin Jones and Dr. Javier Martín-Broto, followed by an interactive Q&A with the co-chairs and speakers. Attendees will also have dedicated networking time to connect, exchange ideas, and continue the conversation beyond the lecture format.
Sarcoma is rare, but the challenges around it are urgent, global, and deeply relevant to the future of precision oncology. This Grand Rounds program is created to turn expert knowledge into meaningful dialogue bringing together people who are advancing care, designing trials, shaping research, and looking for better answers for patients.
The event is supported by Eli Lilly and Company as Foundational Partner and US WorldMeds as Bronze Sponsor.
Join us on Friday, May 29, 2026, from 3:30–5:30 PM Chicago Time at Hilton Chicago for an expert-led evening dedicated to the next era of sarcoma care.
REGISTRATION